Engineered precision forPredictive diagnostic certainty
MEDIX bridges high-fidelity biomedical hardware with deterministic machine learning. Sub-millimeter sensor streams interface directly with edge neural networks to detect clinical anomalies before symptoms emerge.
Custom biomedical arrays capture continuous micro-volt biopotential signals with active ambient noise cancelation, providing uninterrupted clinical signal purity.
Sampling latency
0.02ms real-time
Array precision
Sub-millimeter grid
Hardware standard
ISO 13485 compliant
Biocompatibility
USP Class VI certified
Embedded deep neural architectures evaluate raw patient telemetry continuously, ranking severity risks and cross-referencing multi-lead inputs without cloud latency.
Classification accuracy
99.4% verified
Triage latency
<120ms execution
Validation cohort
1.4M synthetic trials
Inference architecture
Edge-compiled neural net
Clinical safety safeguards
Fail-safe hardware cutoffs and continuous redundancy checks run concurrently on every patient monitor.
Zero-drift auto-calibration
Self-correcting sensor arrays maintain diagnostic baseline fidelity over 18,000 continuous operating hours.
Audited regulatory traceability
Every telemetry packet and algorithmic recommendation includes cryptographically verified audit trails.
Explore complete hardware schematics and clinical trial benchmarks in our technology dossier.
Clinical precision backed by global regulatory standards
Review certified quality management protocols, automated encryption benchmarks, and validated multicenter trial outcomes.
Comprehensive design control, risk management (ISO 14971), and manufacturing trace protocols for active diagnostics.
Substantial equivalence confirmed for clinical decision analytics and wearable continuous physiological telemetry.
Notified body oversight ensuring post-market clinical follow-up (PMCF) and high-density electrical safety compliance.
Download institutional regulatory dossier
Access full clinical trial summaries, FDA 510(k) predicate disclosures, and third-party penetration audit reports.